---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-069441"
form_type: "8-K"
ticker: "INKT"
cik: "0001840229"
company_name: "MiNK Therapeutics, Inc."
filed_at: "2022-03-08T23:59:59+00:00"
generated_at: "2026-06-27T00:53:18.108319+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# MiNK Therapeutics finalizes employment agreements for CEO ($425k) and CSO (£260k)

## Summary
- CEO Dr. Buell: $425,000 base salary, 50% bonus target, compensation retroactive to Jan 1, 2022.
- CSO Dr. van Dijk: £260,000 base salary, £18,000 housing/travel budget, 35% bonus target.
- Without cause termination: Buell receives 12 months salary, bonus, COBRA, and $15k outplacement.
- Change-in-control: Buell gets 18 months salary plus 150% bonus, full vesting acceleration of equity.

## SEC filing metadata
- accession: 0001193125-22-069441
- form_type: 8-K
- ticker: INKT
- cik: 0001840229
- company_name: MiNK Therapeutics, Inc.
- filed_at: 2022-03-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840229/000119312522069441/0001193125-22-069441-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840229/000119312522069441/d69538d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-069441
- JSON: https://secwatch.observer/filing/0001193125-22-069441.json
- Plain text: https://secwatch.observer/filing/0001193125-22-069441.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.